poisar

Stocks · News reference

Amrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

BenzingaAug 6, 2026, 8:52 PMBenzinga Newsdesk

Amrize (NYSE:AMRZ) raises FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.500 billion-$12.700 billion vs $12.464 billion estimate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 6, 2026, 8:52 PM
Checked
Aug 6, 2026, 8:52 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 24, 2026, 9:00 PMSEC EDGAR

    8-K filing — Amrize Ltd (AMRZ)

    Filed: 2026-08-24 AccNo: 0001140361-26-034208 Size: 487 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar